Last reviewed · How we verify

NCT03746730

Role of US,Doppler in Major Salivary Gland Diseases

Status unknown Last updated 20 November 2018
What this trial tests

trial testing ultrasound in Salivary Gland Diseases in 40 participants. Status unknown.

Timeline
1 December 2018
Primary endpoint
1 September 2020
1 October 2020

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment40
Start date1 December 2018
Primary completion1 September 2020
Estimated completion1 October 2020

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Salivary Gland Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the role of gray scale and Doppler ultrasound in characterizing of parotid and submandibular gland lesions in comparison to biopsy if needed

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ultrasound

Trials testing the same drug.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03746730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing